Pinheiro B, Lemos C, Neutzling Kaufmann F, Marques J, da Silva Santos C, Carvalho E, et al. Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin. Brain Res Bull. 2016;124:222-30 pubmed publisher

Alpár A, Tortoriello G, Calvigioni D, Niphakis M, Milenkovic I, Bakker J, et al. Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. Nat Commun. 2014;5:4421 pubmed publisher

Prather P, Francisdevaraj F, Dates C, Greer A, Bratton S, Ford B, et al. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen. Biochem Biophys Res Commun. 2013;441:339-43 pubmed publisher

Maleńczyk K, Jazurek M, Keimpema E, Silvestri C, Janikiewicz J, Mackie K, et al. CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release. J Biol Chem. 2013;288:32685-99 pubmed publisher

Keimpema E, Alpar A, Howell F, Maleńczyk K, Hobbs C, Hurd Y, et al. Diacylglycerol lipase ? manipulation reveals developmental roles for intercellular endocannabinoid signaling. Sci Rep. 2013;3:2093 pubmed publisher

Chimalakonda K, Seely K, Bratton S, Brents L, Moran C, Endres G, et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metab Dispos. 2012;40:2174-84 pubmed publisher

Brents L, Gallus Zawada A, Radominska Pandya A, Vasiljevik T, Prisinzano T, Fantegrossi W, et al. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochem Pharmacol. 2012;83:952-61 pubmed publisher

Brents L, Reichard E, Zimmerman S, Moran J, Fantegrossi W, Prather P. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS ONE. 2011;6:e21917 pubmed publisher